Assenagon Asset Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-55,699
| Closed | -$15K | – | 1502 |
|
|
2022
Q3 | $15K | Buy |
55,699
+19,838
| +55% | +$8.66K | ﹤0.01% | 1318 |
|
|
2022
Q2 | $28K | Sell |
35,861
-241,795
| -87% | -$216K | ﹤0.01% | 1431 |
|
|
2022
Q1 | $297K | Sell |
277,656
-152,899
| -36% | -$278K | ﹤0.01% | 1298 |
|
|
2021
Q4 | $818K | Sell |
430,555
-59,782
| -12% | -$143K | ﹤0.01% | 1087 |
|
|
2021
Q3 | $1.48M | Buy |
490,337
+21,534
| +5% | +$76.7K | ﹤0.01% | 785 |
|
|
2021
Q2 | $1.83M | Sell |
468,803
-131,750
| -22% | -$546K | 0.01% | 707 |
|
|
2021
Q1 | $3.04M | Buy |
600,553
+380,505
| +173% | +$1.97M | 0.01% | 613 |
|
|
2020
Q4 | $900K | Sell |
220,048
-224,876
| -51% | -$1.1M | ﹤0.01% | 769 |
|
|
2020
Q3 | $2.16M | Buy |
+444,924
| New | +$2.43M | 0.01% | 567 |
|
|
2020
Q2 | – | Sell |
-182,012
| Closed | -$597K | – | 1277 |
|
|
2020
Q1 | $597K | Buy |
+182,012
| New | +$959K | ﹤0.01% | 615 |
|
|
2019
Q3 | – | Sell |
-94,050
| Closed | -$356K | – | 1131 |
|
|
2019
Q2 | $356K | Buy |
+94,050
| New | +$385K | ﹤0.01% | 898 |
|
Assenagon Asset Management's AGTC Position: Q4 2022 in Review
Assenagon Asset Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 55,699 shares — an estimated $15K sold.
Assenagon Asset Management first reported a position in AGTC in Q2 2019 and held it in 11 quarters. The position peaked at $3.04M in Q1 2021. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.
- Assenagon Asset Management reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
- Assenagon Asset Management sold 55,699 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $15K.
- Assenagon Asset Management first reported a position in Applied Genetic Technologies Corporation in Q2 2019 and held it in 11 quarters.
- Assenagon Asset Management's Applied Genetic Technologies Corporation position peaked at $3.04M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.
Based on Assenagon Asset Management's 13F filing for Q4 2022, filed 12 Jan 2023.